{
  "title": "Humoral and Cell-Mediated Immune Responses to Vaccinia Virus Immunization",
  "identifier": {
    "identifier": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY28",
    "identifierSource": "http://www.immport.org"
  },
  "producedBy": {  "name": "Humoral and Cell-Mediated Immune Responses to Vaccinia Virus Immunization",
  "performedBy": [
    {
      "firstName": "Gregory",
      "lastName": "Poland",
      "email": "?",
      "affiliations": [
          {
             "name": "Mayo Vaccine Research Group"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    }
  ],
  "studyGroups": [
        {
          "name": "Dryvax vaccine recipients",
          "size": 1092
        }
  ],
  
  "usesReagent": [
        {
          "name": "ELISPOT total IFNg reagents"
        },
        {
          "name": "ELISPOT CD8 IFNg reagents"
        },
        {
          "name": "HLA-A"
        },
        {
          "name": "HLA-B"
        },
        {
          "name": "HLA-C"
        },
        {
          "name": "HLA-DPA1"
        },
        {
          "name": "HLA-DPB1"
        },
        {
          "name": "HLA-DQA1"
        },
        {
          "name": "HLA-DRB1"
        },
        {
          "name": "HLA-DQB1"
        },
        {
          "name": "B-galactosidase based vaccinia neutralization assay"
        },
        {
          "name": "IFN-a"
        },
        {
          "name": "IFN-b"
        },
        {
          "name": "IFN-g"
        },
        {
          "name": "IL-10"
        },
        {
          "name": "IL-12p40"
        },
        {
          "name": "IL-12p70"
        },
        {
          "name": "IL-18"
        },
        {
          "name": "IL-1b"
        },
        {
          "name": "IL-2"
        },
        {
          "name": "IL-4"
        },
        {
          "name": "IL-6"
        },
        {
          "name": "TNF-a"
        },
        {
          "name": "CCR7"
        },
        {
          "name": "CD14"
        },
        {
          "name": "CD19"
        },
        {
          "name": "CD4"
        },
        {
          "name": "CD45RA"
        },
        {
          "name": "CD8"
        },
        {
          "name": "HLA A, B, C"
        },
        {
          "name": "HLA DP, DQ, DR"
        },
        {
          "name": "IgG1"
        },
        {
          "name": "Live/Dead Blue"
        },
        {
          "name": "mIgG1 Isotype"
        },
        {
          "name": "mIgG2a"
        },
        {
          "name": "mIgG2b"
        },
        {
          "name": "rIgG2a"
        }
  ],
  
  "selectionCriteria": [
        {
          "category": "Inclusion",
          "values": [
              "Age 18-30 years"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Received a single dose of Dryvax within the previous 1-48 months"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Known 'take'"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Otherwise generally healthy"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Individuals who volunteer to be in the study"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Indivduals who have unique subject identification number "
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Subjects who have no underlying immunocompromising conditions"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Preclude prior immunization/exposure more than 48 months ago"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Individuals who received a dose with documented 'no take'"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Subjects who have participated in an experimental trial involving an unlicensed smallpox vaccine"
          ]
        }
  ],
  
  "types": [
      {
          "value": "Observational"
      }
  ]
  },
  "creators": [
    {
      "firstName": "Gregory",
      "lastName": "Poland",
      "email": "?",
      "affiliations": [
          {
             "name": "Mayo Vaccine Research Group"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    },
    {
      "name": "Population Genetics Analysis Program: Immunity to Vaccines/Infections",
      "extraProperties": [
        {
          "category": "Catgory",
          "values": [
            {
              "value": "DAIT"
            }
          ]
        },
        {
          "category": "External Id",
          "values": [
            {
              "value": "HHSN266200400065C"
            }
          ]
        },
        {
          "category": "Description",
          "values": [
            {
              "value": "Our broad objective is to examine the role of candidate human immune response gene polymorphisms (and their receptors, expression and function) in inter-individual variability in vaccinia vaccine-induced humoral and cell-mediated immune responses among a cohort of 500 recently vaccinated subjects.  https://www.fbo.gov/index?s=opportunity&mode=form&tab=core&id=4fe38afb31cad52ce3d9ce016a3990bb"
            }
          ]
        }
      ]
    }
  ],
  
  "primaryPublications": [
    {
      "identifier":
        {
          "identifier": "19038260",
          "identifierSource": "pubmed"
        },
      "authorsList": "Ryan JE(1), Dhiman N, Ovsyannikova IG, Vierkant RA, Pankratz VS, Poland GA.",
      "title": "Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination.",
      "publicationVenue": "J Immunol Methods.",
      "dates": [
        {
          "date": "2009",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "22949304",
          "identifierSource": "pubmed"
        },
      "authorsList": "Haralambieva IH(1), Oberg AL, Dhiman N, Ovsyannikova IG, Kennedy RB, Grill DE, Jacobson RM, Poland GA.",
      "title": "High-dimensional gene expression profiling studies in high and low responders to  primary smallpox vaccination.",
      "publicationVenue": "J Infect Dis.",
      "dates": [
        {
          "date": "2012",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "23594957",
          "identifierSource": "pubmed"
        },
      "authorsList": "Kennedy RB(1), Oberg AL, Ovsyannikova IG, Haralambieva IH, Grill D, Poland GA.",
      "title": "Transcriptomic profiles of high and low antibody responders to smallpox vaccine.",
      "publicationVenue": "Genes Immun.",
      "dates": [
        {
          "date": "2013",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "23806267",
          "identifierSource": "pubmed"
        },
      "authorsList": "Haralambieva IH(1), Ovsyannikova IG, Kennedy RB, Larrabee BR, Shane Pankratz V, Poland GA.",
      "title": "Race and sex-based differences in cytokine immune responses to smallpox vaccine in healthy individuals.",
      "publicationVenue": "Hum Immunol.",
      "dates": [
        {
          "date": "2013",
          "type": { "value": "publication year" }
        }
      ]
    }
  ],
  "types": [
      {
        "value": "Observational"
      },
      {
        "value": "Vaccine Response"
      }
  ],
  "dates": [
      {
          "date": "2010-11-14",
          "type": {
              "value": "final_public_release_date"
          }
      }
  ],
  "availability": "Available for download after registration with ImmPort",
  "refinement": "Curated",
  "dimensions": [{
        "name": {
            "value": "Cellular Quantification"
        },
        "description": "An ELISPOT-based assay of the number of vaccinia-specific IFN-g-producing cells in total PBMC after in vitro restimulation with inactivated vaccinia virus.",
        "types": [
            {
               "value": "ELISPOT"
            }
        ]
      },{
        "name": {
            "value": "Cellular Quantification"
        },
        "description": "An ELISPOT-based assay of the number of vaccinia-specific IFN-g producing CD8+ T cells after in vitro restimulation with inactivated vaccinia virus.",
        "types": [
            {
               "value": "ELISPOT"
            }
        ]
      },{
        "name": {
            "value": "Genotyping"
        },
        "description": "HLA Typing for 8 Loci: HLA-A, B, C, DRB1, DQA1, DQB1, DPA1 and DPB1.",
        "types": [
            {
               "value": "HLA TYPING"
            }
        ]
      },{
        "name": {
            "value": "Genotyping"
        },
        "description": "An Illumina-based and/or TaqMan-based assay of single nucleotide polymorphisms associated with known cytokine and cytokine receptor genes.To obtain these genotyping results, please follow the process described <a href='https://immport.niaid.nih.gov/docs/GT_Data_Request_Process.pptx'>here</a>. To download the Genotyping Data Request form, click <a href='https://immport.niaid.nih.gov/docs/GT_Data_Request_Form-v-3.docx'>here</a>.",
        "types": [
            {
               "value": "Array"
            }
        ]
      },{
        "name": {
            "value": "Cytokine Quantification"
        },
        "description": "An ELISA-based assay of the ability of serum anti-vaccin ia antibodies to inhibit infection of HeLa cells by recombinant vaccinia virus e xpressing Beta-galactosidase, serum dilution inhibiting 50% of virus activity (ID50 )",
        "types": [
            {
               "value": "ELISA"
            }
        ]
      },{
        "name": {
            "value": "Cytokine Quantification"
        },
        "description": "PBMC were stimulated in triplicate with either HeLa cell lysate or UV-inactivated vaccinia virus (MOI of 1). Cell culture supernatants were removed after both an early (24-48 hour) and late (3-5 days) time-point and stored at -80 degrees C until the time of assay. Exact time-points were determined after optimization assays. The supernatants were analyzed by ELISA for the quantification of IL-1b, IL-2, IL -4, IL-6, IL-10, IL-12(p35 and p40), IL-18, TNF-a, IFN-a, IFN-b, and IFN-g secretion.",
        "types": [
            {
               "value": "ELISA"
            }
        ]
      },{
        "name": {
            "value": "Transcript Quantification"
        },
        "description": "Assessment of the cell-mediated immune response to Vaccinia immunization",
        "types": [
            {
               "value": "Array"
            }
        ]
      },{
        "name": {
            "value": "Genotyping"
        },
        "description": "An Illumina-based assay of more than 500,000 single nucleotide polymorphisms spanning the entire genome. Measurement Technique: Illumina Infinium BeadChip Assay; 650K for subjects and controls self-reporting as African American; 550K for all others. Total 1000 subjects; 1000 subjects and controls on 550K; Out of 1000 subjects, 300 self-reported African American subjects and controls are also for 650 platform (~86K SNPs).To obtain these genotyping results, please follow the process described <a href='https://immport.niaid.nih.gov/docs/GT_Data_Request_Process.pptx'>here</a>. To download the Genotyping Data Request form, click <a href='https://immport.niaid.nih.gov/docs/GT_Data_Request_Form-v-3.docx'>here</a>.",
        "types": [
            {
               "value": "Array"
            }
        ]
      },{
        "name": {
            "value": "Genotyping"
        },
        "description": "An Illumina-based assay of more than 500,000 single nucleotide polymorphisms spanning the entire genome. Measurement Technique: Illumina Infinium BeadChip Assay; 650K for subjects and controls self-reporting as African American; 550K for all others. Total 1000 subjects; 1000 subjects and controls on 550K; Out of 1000 subjects, 300 self-reported African American subjects and controls are also for 650 platform (~86K SNPs).To obtain these genotyping results, please follow the process described <a href='https://immport.niaid.nih.gov/docs/GT_Data_Request_Process.pptx'>here</a>. To download the Genotyping Data Request form, click <a href='https://immport.niaid.nih.gov/docs/GT_Data_Request_Form-v-3.docx'>here</a>.",
        "types": [
            {
               "value": "Array"
            }
        ]
      },{
        "name": {
            "value": "Molecular Quantification"
        },
        "description": "A flow cytometry-based assay of HLA class I and class II cell surface expression by CD4+ and CD8+ cells from a mixture of PBMC restimulated in vitro with inactivated vaccinia virus",
        "types": [
            {
               "value": "Flow Cytometry"
            }
        ]
      }
      
  ],
  "isAbout": [
        {
          "name": "Stimulated with vaccinia virus for IFN-alpha ELISA"
        },
        {
          "name": "Unstimulated with vaccinia virus for IFN-alpha ELISA"
        },
        {
          "name": "Stimulated with vaccinia virus for IFN-beta ELISA"
        },
        {
          "name": "Unstimulated with vaccinia virus for IFN-beta ELISA"
        },
        {
          "name": "Stimulated with vaccinia virus for IFN-gamma ELISA"
        },
        {
          "name": "Unstimulated with vaccinia virus for IFN-gamma ELISA"
        },
        {
          "name": "Stimulated with vaccinia virus for IL-10 ELISA"
        },
        {
          "name": "Unstimulated with vaccinia virus for IL-10 ELISA"
        },
        {
          "name": "Stimulated with vaccinia virus for IL-12p40 ELISA"
        },
        {
          "name": "Unstimulated with vaccinia virus for IL-12p40 ELISA"
        },
        {
          "name": "Stimulated with vaccinia virus for IL-12p70 ELISA"
        },
        {
          "name": "Unstimulated with vaccinia virus for IL-12p70 ELISA"
        },
        {
          "name": "Stimulated with vaccinia virus for IL-18 ELISA"
        },
        {
          "name": "Unstimulated with vaccinia virus for IL-18 ELISA"
        },
        {
          "name": "Stimulated with vaccinia virus for IL-1b ELISA"
        },
        {
          "name": "Unstimulated with vaccinia virus for IL-1b ELISA"
        },
        {
          "name": "Stimulated with vaccinia virus for IL-2 ELISA"
        },
        {
          "name": "Unstimulated with vaccinia virus for IL-2 ELISA"
        },
        {
          "name": "Stimulated with vaccinia virus for IL-4 ELISA"
        },
        {
          "name": "Unstimulated with vaccinia virus for IL-4 ELISA"
        },
        {
          "name": "Stimulated with vaccinia virus for IL-6 ELISA"
        },
        {
          "name": "Unstimulated with vaccinia virus for IL-6 ELISA"
        },
        {
          "name": "Stimulated with vaccinia virus for TNF-alpha ELISA"
        },
        {
          "name": "Unstimulated with vaccinia virus for TNF-alpha ELISA"
        }
  ],
  "distributions": [
      {
          "identifier": {
              "identifier": "SDY28",
              "identifierSource": "ImmPort"
          },
          "title": "Humoral and Cell-Mediated Immune Responses to Vaccinia Virus Immunization",
          "access": {
              "landingPage": "http://www.immport.org",
              "accessURL": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY28",
              "types": [
                  {
                      "value": "Download tab separated files"
                  },
                  {
                      "value": "Download MySQL files and schema"
                  }
              ],
              "authorizations": [
                {
                    "value": "Registraton with ImmPort required"
                }
              ]
          },
          "storedIn": {
              "name": "ImmPort",
              "types": [
                {
                  "value": "primary repository"
                }
              ]
         },
         "licenses": [
           {
             "name": "ImmPort User Agreement",
             "version": "1.0",
             "extraProperties": [
               {
                 "category": "Link to User Agreement",
                 "values": [
                   {
                     "value": "http://www.immport.org/agreement"
                   }
                 ]
               }
             ]
           }
         ]
      }
  ],
  "acknowledges": [
    {
      "identifier": {
        "identifier": ""
      },
      "name": "Population Genetics Analysis Program: Immunity to Vaccines/Infections",
      "extraProperties": [
        {
          "category": "Link",
          "values": [
            {
              "value": "None"
            }
          ]
        }
      ]}
  ],
  "licenses": [
    {
      "name": "ImmPort User Agreement",
      "version": "1.0",
      "extraProperties": [
        {
          "category": "Link to User Agreement",
          "values": [
            {
              "value": "http://www.immport.org/agreement"
            }
          ]
        }
      ]
    }
  ],
  "description": "Our broad objective is to examine the role of candidate human immune response gene polymorphisms (and their receptors, expression and function) in inter-individual variability in vaccinia vaccine-induced humoral and cell-mediated immune responses among a cohort of 1,000 vaccinated subjects."
}
